Moldoveanu E - Search Results

1

Antioxidant defense capacity in scleroderma patients.

Sfrent-Cornateanu R, Mihai C, Stoian I, Lixandru D, Bara C, Moldoveanu E. Sfrent-Cornateanu R, et al. Among authors: moldoveanu e. Clin Chem Lab Med. 2008;46(6):836-41. doi: 10.1515/CCLM.2008.132. Clin Chem Lab Med. 2008. PMID: 18601607

2

The IL-6 promoter polymorphism is associated with disease activity and disability in systemic sclerosis.

Sfrent-Cornateanu R, Mihai C, Balan S, Ionescu R, Moldoveanu E. Sfrent-Cornateanu R, et al. Among authors: moldoveanu e. J Cell Mol Med. 2006 Oct-Dec;10(4):955-9. doi: 10.1111/j.1582-4934.2006.tb00538.x. J Cell Mol Med. 2006. PMID: 17125598 Free article.

3

Apoptosis and free radicals.

Stoian I, Oros A, Moldoveanu E. Stoian I, et al. Among authors: moldoveanu e. Biochem Mol Med. 1996 Dec;59(2):93-7. doi: 10.1006/bmme.1996.0072. Biochem Mol Med. 1996. PMID: 8986629 Review.

4

Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus.

Serban M, Tanaseanu C, Kosaka T, Vidulescu C, Stoian I, Marta DS, Tanaseanu S, Moldoveanu E. Serban M, et al. Among authors: moldoveanu e. J Cell Mol Med. 2002 Oct-Dec;6(4):643-7. doi: 10.1111/j.1582-4934.2002.tb00462.x. J Cell Mol Med. 2002. PMID: 12611648 Free PMC article.

5

Apoptosis, I: General considerations.

Oros A, Moldoveanu E, Stoian I, Popescu LM. Oros A, et al. Among authors: moldoveanu e. Rom J Morphol Embryol. 1995 Jul-Dec;41(3-4):89-99. Rom J Morphol Embryol. 1995. PMID: 8772362 Review.

6

BCL-2--general considerations.

Moldoveanu E, Stoian I, Voinea L, Marta D, Popescu LM. Moldoveanu E, et al. Haematologia (Budap). 1998;29(3):167-80. Haematologia (Budap). 1998. PMID: 10069443 Review.

7

Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.

Moldoveanu E, Mut-Vitcu B, Tanaseanu GR, Marta DS, Manea G, Kosaka T, Vidulescu C, Tanaseanu C. Moldoveanu E, et al. Clin Biochem. 2008 Dec;41(18):1429-33. doi: 10.1016/j.clinbiochem.2008.09.109. Epub 2008 Oct 7. Clin Biochem. 2008. PMID: 18930040

8

Lipoprotein-associated phospholipase A2, myeloperoxidase and vascular endothelial growth factor - predictors of high vascular risk in respiratory bacterial infections.

Seri A, Marta DS, Madalan A, Popescu M, Tiglea AI, Moldoveanu E. Seri A, et al. Among authors: moldoveanu e. J Med Life. 2016 Oct-Dec;9(4):429-433. J Med Life. 2016. PMID: 27928450 Free PMC article.

9

Lipoprotein-associated phospholipase A2 activity in patients with preserved left ventricular ejection fraction.

Moldoveanu E, Serban M, Marta DS, Serban I, Huica R. Moldoveanu E, et al. Biomarkers. 2011 Nov;16(7):587-9. doi: 10.3109/1354750X.2011.611597. Epub 2011 Sep 26. Biomarkers. 2011. PMID: 21942556

10

Patients with primary antiphospholipid syndrome and coronary microvascular dysfunction--a distinct clinical subset.

Tănăseanu C, Moldoveanu E, Tănăseanu S, Popescu M, Dumitraşcu A, Tamşulea I, Urban A, Grecu V, Neagu M, Manea G, Marta D. Tănăseanu C, et al. Among authors: moldoveanu e. Rom J Intern Med. 2004;42(3):545-56. Rom J Intern Med. 2004. PMID: 16370053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters